Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT03448718 |
| Title | Trial of Olaparib in Patients With Metastatic Urothelial Cancer Harboring DNA Damage Response Gene Alterations |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | Yes |
| Sponsors | Matthew Galsky |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| University of Chicago Medical Center | Chicago | Illinois | 60637 | United States | Details | |
| Johns Hopkins Sidney Kimmel Comprehensive Cancer Center | Baltimore | Maryland | 21287 | United States | Details | |
| Karmanos Cancer Center (Wyane State University) | Detroit | Michigan | 48201 | United States | Details | |
| Icahn School of Medicine at Mount Sinai | New York | New York | 10029-6542 | United States | Details | |
| University of North Carolina at Chapel Hill | Chapel Hill | North Carolina | 27599 | United States | Details | |
| Vanderbilt-Ingran Cancer Center | Nashville | Tennessee | 37232 | United States | Details | |
| Huntsman Cancer Institute University of Utah | Salt Lake City | Utah | 84112-5550 | United States | Details |